Cera, a UK-based in-home healthcare provider, has raised $150 million in a combination of debt and equity to expand its AI-powered platform amid increasing pressure on public healthcare systems. The funding round, led by BDT & MSD Partners and Schroders Capital, aims to scale Cera's technology, which reportedly predicts patient risks with over 80% accuracy. This follows a significant $320 million raise in 2022. The company claims to have reduced hospitalizations by up to 70% and is now the largest non-NHS healthcare provider in the UK, serving 30 million people.